CREATE AN
ACCOUNT VIRTUAL
DISPLAY HALL

Individual CE

The educational sessions in this section have been specially developed to meet the current needs of NPs. NPACE’s annually asks thousands of NPs to define their practice concerns across the primary care spectrum. Then, we build educational content using the nation’s top speakers who present sessions uniquely crafted to meet those primary care and pharmacology needs. 

Here, you may filter by category, such as women’s health or diabetes, alphabetically or by date. Click the “View” button to read the Course Description, Course Objectives, Speaker information, CNE Information and Disclosures. From pediatrics to dermatology or cardiology to orthopedics – we have you covered. 

Do you like what you see?  Click “Register” and follow the instructions to view the video recording for up to one year.  Successful completion of the post-test is required for CE credits to be granted.

On-Demand Individual CE

Search by Category
Search by Format
Sort By

215 Results

  • (DEA) MATE Act - Substance Use Disorder Bundle

    In accordance with the Medication Access and Training Expansion (MATE) Act, beginning June 7, 2023, all providers who are registered with the DEA are required to complete 8 hours of training on the treatment and management of patients with opioid and other substance use disorders. This bundle fully satisfies this one-time requirement. 

    Total Credits: 9.00 contact hours; 8.5 are pharmacology
    Expiration Date: June 30, 2024
    $225 

  • Acute Care Bundle 2024

    As we know, patients are more acutely ill than ever. This 8-course bundle covers caring for patients with sepsis, infective endocarditis, acute respiratory failure, and fractures. Ventilator management, end of life care, and diagnostic testing/imaging are also addressed. This is a must have!

    Total Credits: 8.00 contact hours; 2.83 are pharmacology
    Expiration Date: December 31st, 2024
    $175.00   $210.00

  • Addressing Barriers in Vaccination Uptake and Integration

    Merck Grant Funded Program

    The overall goal of this program is to address the barriers in vaccination uptake and integration. 

    Credits: 1.0 contact hours; 1.0 are Pharmacology

    $10.00

  • Adolescent Substance Use Disorder

    Adolescent substance use has followed familiar trends for several decades with alcohol, nicotine, and cannabis leading other drugs in popularity. After several years of declining nicotine use, primarily via combustible cigarettes, recent data suggests a resurgence of nicotine use, primarily via e-cigarettes as well as a marked increase in cannabis use, likely corresponding with legalization efforts. Additionally, there has been an increase in hallucinogen use and the dangers of opioid use have heightened due to the rise of illicit fentanyl being brought in from outside the United States. This lecture will review the most recent Monitoring the Future study and discuss implications of adolescent substance use trends on healthcare providers.

    Credits: 1.50 Contact Hours; 1.50 are Pharmacology
    Expiration Date: December 31st, 2024

    $40

  • Alzheimer’s Dementia: The Hippo in the Room

    Alzheimer’s disease is the most common cause of dementia. The etiology is unknown and there is no known cure for this devastating progressive neurodegenerative disease. The hippocampus is affected and prevents the patient from forming new memories. The patient often recognizes it but doesn’t want to talk about the “hippo” in the room. With more than 6 million American’s living with Alzheimer’s disease and a projected doubling of that number, nurse practitioners should be knowledgeable about the disease.

    Credits: 1.0 contact hours; 0.33 are pharmacology
    Expiration Date: December 31, 2024
    $10.00

  • Analyzing Existing Evidence to Inform Appropriate Use of Antivirals for Influenza and COVID-19 Infections

    Influenza and COVID-19 are both respiratory illnesses that can cause serious complications, especially in high-risk populations. Nurse practitioners play a key role in the diagnosis and treatment of influenza and COVID-19 infections. This presentation will evaluate the different types of antiviral medications and their pharmacologic features. Patient populations who are most likely to benefit from antiviral therapy will be reviewed. This presentation will examine the most up to date evidence related to efficacy and safety of antivirals for influenza and COVID-19, and provide an approach to the appropriate use of these medications in clinical practice.

    Credits: 1.50 Contact Hours; 1.50 are Pharmacology

    $40

  • Anemia/Hematology

    An understanding of basic hematology is essential to diagnosing and treating common conditions like anemia. Identifying the presence of anemia is only the first step in the management of this condition. Determining the cause or causes of anemia is critical to appropriate management and prevention of recurrence. This presentation will discuss red blood cell production, common anemia etiologies, identification of anemia type from hemograms, management and evaluation of treatment.

    Credits: 1.00 contact hours; 0.5 are pharmacology
    $30

  • An Evidence-Based Approach to Maximizing Benefit & Limiting Antibiotic Risks in Community-Acquired Pneumonia

    In 2019, the Infectious Disease Society of America and American Thoracic Society published updated recommendations for managing patients with community-acquired pneumonia (CAP) generating new considerations for inpatient and outpatient practitioners. This presentation will assess emerging literature influencing the optimal pharmacologic management of CAP such as, changing etiologic trends, patient-specific factors, outcomes evidence, and risk factors for adverse drug reactions.

    Credits: 1.50 Contact Hours; 1.50 are Pharmacology

    $40

  • Antibiotic Update 2023: Respiratory Infections in the Challenging Patient

    This session will provide the nurse practitioner with information regarding common pathogens implicated in AECB and community acquired pneumonia in the patient with underlying co-morbidities such as asthma, COPD and alcohol abuse.  Current recommendations regarding antimicrobial treatment options will be reviewed in detail.  National recommendations for obtaining chest x-ray and sputum for gram staining will also be discussed.

    Credits: 1.50 Contact Hours; 1.50 are Pharmacology
    Expiration Date: December 31st, 2024

    $45

  • Anxiously Awaited: Neurobiology & Personalized Treatment of Anxiety

    Updated diagnostic criteria and disease models for anxiety disorders are reviewed. Neurobiological and epigenetic mechanisms that underlie anxiety symptoms are presented as the basis for therapeutic interventions. Specific attention is given to the formulation of rational, genomically-informed pharmacologic treatment approaches for anxiety disorders. Practical applications for nurse practitioners are presented.

    Credits: 1.50 Contact Hours; 1.50 are Pharmacology
    $40